FDA-approved indications:
Immune thrombocytopenic purpura
Kawasaki
Common variable immunodeficiency, primary immunodeficiency associated with humoral imunodeficiency
Kidney transplant with high antibody recipient or ABO incompatible donor
Chronic B-cell leukemia, stem cell transplantation
Off-label indications
TTP, HUS
Aplastic anemia, autoimmune hemolytic anemia
Myasthenia gravis, Lambert-Eaton myasthenic syndrome
Guillain-Barre syndrome
Anti-NMDA receptor encephalitis
Severe Pyoderma, severe Pemphigus vulgaris
Acute GVHD
Immune-mediated neutropenia
Recurrent C. diff
Immune thrombocytopenic purpura
Kawasaki
Common variable immunodeficiency, primary immunodeficiency associated with humoral imunodeficiency
Kidney transplant with high antibody recipient or ABO incompatible donor
TTP, HUS
Aplastic anemia, autoimmune hemolytic anemia
Myasthenia gravis, Lambert-Eaton myasthenic syndrome
Guillain-Barre syndrome
Anti-NMDA receptor encephalitis
Severe Pyoderma, severe Pemphigus vulgaris
Acute GVHD
Immune-mediated neutropenia
Recurrent C. diff
Intravenous immunoglobulin
Plasmapheresis
Extracorporeal membrane oxygenation
Ribavirin
Cyclosporine
Exchange transfusion
Interferon-α
Sotrovimab